Bioventus Inc
NASDAQ:BVS
Bioventus Inc
Revenue
Bioventus Inc
Revenue Peer Comparison
Competitive Revenue Analysis
Latest Figures & CAGR of Competitors
Company | Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
B
|
Bioventus Inc
NASDAQ:BVS
|
Revenue
$512.1m
|
CAGR 3-Years
15%
|
CAGR 5-Years
12%
|
CAGR 10-Years
N/A
|
Cooper Companies Inc
NYSE:COO
|
Revenue
$3.7B
|
CAGR 3-Years
14%
|
CAGR 5-Years
7%
|
CAGR 10-Years
9%
|
|
DENTSPLY SIRONA Inc
NASDAQ:XRAY
|
Revenue
$4B
|
CAGR 3-Years
6%
|
CAGR 5-Years
0%
|
CAGR 10-Years
3%
|
|
Align Technology Inc
NASDAQ:ALGN
|
Revenue
$3.9B
|
CAGR 3-Years
12%
|
CAGR 5-Years
14%
|
CAGR 10-Years
19%
|
|
Lantheus Holdings Inc
NASDAQ:LNTH
|
Revenue
$1.3B
|
CAGR 3-Years
56%
|
CAGR 5-Years
30%
|
CAGR 10-Years
16%
|
See Also
What is Bioventus Inc's Revenue?
Revenue
512.1m
USD
Based on the financial report for Dec 31, 2022, Bioventus Inc's Revenue amounts to 512.1m USD.
What is Bioventus Inc's Revenue growth rate?
Revenue CAGR 5Y
12%
Over the last year, the Revenue growth was 19%. The average annual Revenue growth rates for Bioventus Inc have been 15% over the past three years , 12% over the past five years .